Additionally, patients with AMS presented with significantly higher neutrophil-to-lymphocyte ratio and CRP, which are risk factors of poor health outcomes and possible predictors of severe disease [27–30]. The gene discussed is CRP; the disease is ablepharon macrostomia syndrome.